{
    "ticker": "BCDA",
    "name": "BioCardia, Inc.",
    "description": "BioCardia, Inc. is a biotechnology company dedicated to the development of innovative cardiovascular therapies. Founded in 2004, BioCardia focuses on improving patient outcomes through advanced regenerative medicine techniques. The company\u2019s proprietary technologies include the CardiAMP cell therapy system, which is designed to enhance the delivery of stem cells to the heart to promote tissue regeneration after heart attacks. BioCardia aims to address significant unmet medical needs in the treatment of heart disease, which remains the leading cause of death globally. With a robust pipeline of clinical trials, the company is committed to rigorous research and development efforts, collaborating with leading academic institutions and medical professionals. BioCardia's mission is to leverage its advanced technologies to bring transformative therapies to patients, ultimately improving their quality of life and longevity.",
    "industry": [
        "Biotechnology",
        "Healthcare"
    ],
    "headquarters": "San Carlos, California, USA",
    "founded": "2004",
    "website": "https://www.biocardia.com",
    "ceo": "Peter W. H. M. H. F. G. H. Van Der Sande",
    "social_media": {
        "twitter": "https://twitter.com/BioCardia",
        "linkedin": "https://www.linkedin.com/company/biocardia/"
    },
    "investor_relations": "https://www.biocardia.com/investors",
    "key_executives": [
        {
            "name": "Peter W. H. M. H. F. G. H. Van Der Sande",
            "position": "CEO"
        },
        {
            "name": "Michael J. C. E. C. D. H. E. D. E. H. K. B. R. H. M. H. A. R. A. R. M. H. U. M.",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Therapeutics",
            "products": [
                "CardiAMP Cell Therapy"
            ]
        }
    ],
    "seo": {
        "meta_title": "BioCardia, Inc. | Innovative Cardiovascular Therapies",
        "meta_description": "Learn about BioCardia, Inc., a leader in developing regenerative therapies for cardiovascular diseases. Explore their innovative technologies and commitment to patient care.",
        "keywords": [
            "BioCardia",
            "Cardiovascular Therapies",
            "Stem Cell Therapy",
            "Regenerative Medicine",
            "Biotechnology"
        ]
    },
    "faq": [
        {
            "question": "What is BioCardia known for?",
            "answer": "BioCardia is known for developing innovative therapies for cardiovascular diseases, particularly through its CardiAMP cell therapy system."
        },
        {
            "question": "Who is the CEO of BioCardia?",
            "answer": "Peter W. H. M. H. F. G. H. Van Der Sande is the CEO of BioCardia, Inc."
        },
        {
            "question": "Where is BioCardia headquartered?",
            "answer": "BioCardia is headquartered in San Carlos, California, USA."
        },
        {
            "question": "What are BioCardia's main products?",
            "answer": "BioCardia's main product is the CardiAMP cell therapy system."
        },
        {
            "question": "When was BioCardia founded?",
            "answer": "BioCardia was founded in 2004."
        }
    ],
    "competitors": [
        "CERE",
        "PLSE",
        "BTAI",
        "XLRN"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "VRTX",
        "REGN"
    ]
}